20.01.2013 Views

hoods better to tell their stories than - Allegheny West Magazine

hoods better to tell their stories than - Allegheny West Magazine

hoods better to tell their stories than - Allegheny West Magazine

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

44 <strong>Allegheny</strong> <strong>West</strong> <strong>Magazine</strong> September/Oc<strong>to</strong>ber 2012<br />

Heritage Valley News<br />

The American College of Endocrinology (ACE), the educational and<br />

scientific arm of the American Association of Clinical Endocrinologists<br />

(AACE), inducted Heritage Valley Health System Endocrinologist Noah<br />

Lubowsky, MD, FACE as a Fellow during its 20 th Annual Convocation<br />

ceremony.<br />

The Heritage Valley Sewickley Foundation welcomed Terri Tunick<br />

and Susan Cox <strong>to</strong> its Board of Direc<strong>to</strong>rs.<br />

Terri Tunick is a retired nurse manager and educa<strong>to</strong>r and is active<br />

with several community organizations. She also coordinates the<br />

annual Unique Boutique fundraising event for Heritage Valley<br />

Sewickley Foundation, which will be held this year at the Edgeworth<br />

Club on November 10.<br />

Susan Cox is a former New York City public schools teacher and<br />

continues <strong>to</strong> serve in various educational roles at Edgeworth<br />

Elementary. She is also involved with several community activities and<br />

organizations in the Sewickley area.<br />

Neither aspirin nor warfarin is superior for preventing a combined risk<br />

of death, stroke, and cerebral hemorrhage in heart failure (HF) patients<br />

with normal heart rhythm, according <strong>to</strong> the ten-year WARCEF (Warfarin<br />

and Aspirin for Reduced Cardiac Ejection Fraction) trial. The trial, which<br />

was supported by the National Institute for Neurological Disorders and<br />

Stroke, part of the National Institutes of Health, was published May 2 in<br />

the New England Journal of Medicine.<br />

The WARCEF trial is the largest double-blind comparison of these<br />

medications for heart failure, including 2,305 patients for up <strong>to</strong> six years<br />

at 168 study sites in 11 countries on three continents. The Heritage<br />

Valley Heart & Vascular Center, part of Heritage Valley Health System,<br />

was one of the lead participating sites, having been involved with the<br />

WARCEF trial since 2006.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!